http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4428486-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-4428486-B1 |
| titleOfInvention | Fibrous activator |
| abstract | Disclosed is a treatment using a more effective and safe drug for the treatment or prevention of metabolic syndrome and various diseases closely related thereto. A fibrinolytic activator comprising a low molecular weight fucoidan as an active ingredient is provided. Low molecular weight fucoidan is a more effective and safe drug for the treatment or prevention of metabolic syndrome and its closely related thrombosis, hyperglycemia, hyperlipidemia, and insulin resistance. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456464-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106573057-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106573057-B |
| priorityDate | 2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.